Article Text

Download PDFPDF
Sildenafil use in congenital diaphragmatic hernia
  1. L Hunter1,
  2. T Richens2,
  3. C Davis1,
  4. G Walker1,
  5. J H Simpson1
  1. 1
    Neonatal Intensive Care Unit, Royal Hospital for Sick Children, Glasgow, UK
  2. 2
    Department of Cardiology, Royal Hospital for Sick Children, Glasgow, UK
  1. Correspondence to Lindsey Hunter, Flat 3/2, 15 Malta Terrace, Glasgow G5 OTN, UK; lhunter{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The postnatal management of severe congenital diaphragmatic hernia (CDH) remains challenging with few robust evidence-based interventions but many therapies based on case reports or small case series. A good example of this is sildenafil, a phosphodiesterase inhibitor, which is increasingly used in the management of pulmonary hypertension associated with CDH.1 2

We retrospectively audited sildenafil use in all infants with CDH managed in the co-located Queen Mother’s Hospital and the Royal Hospital for Sick Children, …

View Full Text


  • Competing interests None declared.

Linked Articles

  • Fantoms
    Martin Ward Platt
  • PostScript
    C A Ryan C P Hawkes E M Dempsey